• Youtube Icon
  • Twitter icon
  • Instagram icon
  • LinkedIn icon
  • Facebook icon

Research, monitoring and evaluation

All projects


    Self-assessment tool to measure HIV programmes against global standard

    Genesis Analytics was contracted by the Bill & Melinda Gates Foundation to develop a tool that could help countries to define the performance of their HIV programmes against a global standardised set of programmatic components.


    Testing SA as a market for MAPS technology to reduce HIV risk

    Genesis was contracted by PATH to explore the hypothetical acceptability, programmatic fit and usability of microarray patches (MAPS) technology in South Africa.


    Looking for best practice in HIV prevention for young women

    Genesis was appointed by the Bill & Melinda Gates Foundation to work with key country stakeholders to consolidate and synthesise research findings and review the implementation of best practices of adolescent girls and young women HIV prevention programmes in South Africa.


    Monitoring inclusion on male sex-partners in HIV prevention

    Genesis Analytics was contracted by the Bill & Melinda Gates Foundation to document the extent to which research with male sexual partners (MSPs) had been undertaken as part of the DREAMS programme, the methods used, and the use of results to inform programming in 10 high-burden countries in sub-Saharan Africa.


    Genesis surveys impact of COVID on healthcare utilisation

    Genesis has been contracted by the National Institute for Communicable Diseases (NICD) to conduct a cross-sectional survey of healthcare utilisation and seroprevalence during the COVID-19 pandemic in three provinces in South Africa.


    Innovative solution to improve access and ease of chronic care

    Genesis supported the Cipla Foundation in an innovative solution to expand the footprint of Centralised Chronic Medicines Dispensing Distribution (CCMDD) locations as a solution for chronic patients to pick up their medicines from decentralised locations.


    Tools to measure success of global bilharzia treatment programme

    Merck contracted Genesis to develop programme key performance indicators (KPIs) and an M&E framework to efficiently monitor correct tablet distribution and use at country and community levels of its anti-bilharzia drug Praziquantel (PZQ). Merck has provided nearly one billion PZQ tablets to the World Health Organisation (WHO), which then distributes these to countries for mass drug administration in endemic areas.


    Evaluating NHI Phase 1 pilot implementation for Department of Health

    Genesis undertook the evaluation of the Phase 1 implementation of the government’s policy of National Health Insurance (NHI) in South Africa. The main aim was to assess whether the NHI Phase 1 interventions had achieved their objective of health system strengthening in primary health care facilities.


    Sexual and reproductive services will improve health of SA's youth

    Genesis Analytics supported the Department of Basic Education (DBE) to investigate the understanding, accessibility and acceptability of providing sexual and reproductive health (SRH) services to boys and girls attending school in South Africa.


    Raising the drinking age to 21: Pros and cons

    The National Economic and Development Labour Council (Nedlac) commissioned Genesis Analytics to conduct an urgent independent study on the likely economic, health and social impacts of some of the amendments proposed in the Liquor Amendment Bill, 2017.


    Campaign does improve men's perceptions on HIV testing

    South Africans (18-34 years) who are exposed to the Testa Boy campaign are 50% more likely to agree that men who test for HIV are strong and responsible, according to a study done by Genesis Analytics for the Centre for Communication Impact.


    SA cities sign up to meet 90-90-90 targets

    UNAIDS contracted Genesis to support the meeting of 19 South African municipalities to implement its 90-90-90 project that assists countries to control the HIV epidemic by setting ambitious targets to get people on antiretroviral (ARV) treatment and ensure they are virally suppressed.


    HIV prevention strategy for the Gates Foundation

    The HIV prevention field is changing rapidly as treatment becomes widely available and as new prevention technologies reach the market. The BMGF commits significant funding to healthcare and HIV, and needs to decide whether its strategic focus areas are appropriate in this changing landscape.

Sign up to Genesis News

for the latest news and information